Marchex (MCHX) Cash & Equivalents (2010 - 2025)

Marchex (MCHX) has 16 years of Cash & Equivalents data on file, last reported at $9.9 million in Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 22.13% year-over-year to $9.9 million in Q4 2025; TTM through Dec 2025 was $9.9 million, a 22.13% decrease from a year earlier, with the FY2025 full-year figure at $9.9 million, down 22.13% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $9.9 million, down from $10.3 million in the prior quarter.
• Over the last five years, Cash & Equivalents for MCHX reached as high as $28.2 million in Q1 2021 and fell as low as $9.9 million in Q4 2025.
• Historically, Cash & Equivalents has averaged $17.6 million across 5 years, with a median of $14.4 million in 2023.
• Across the five-year window, Cash & Equivalents retreated 10.77% in 2022 and plunged 43.1% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $27.1 million in 2021, then decreased by 24.41% to $20.5 million in 2022, then decreased by 28.66% to $14.6 million in 2023, then slipped by 12.6% to $12.8 million in 2024, then decreased by 22.13% to $9.9 million in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $9.9 million in Q4 2025, $10.3 million in Q3 2025, and $10.5 million in Q2 2025.